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Sulfhydryl groupAbstract Background: Sirtuin-1 (SIRT-1), a protein has been found to protect the cells against
oxidative stress due to its deacetylase activity.
In this investigation, we aimed to study SIRT-1 gene rs2273773 C > T single nucleotide polymor-
phism and markers of serum protein oxidation (protein carbonyl and sulfhydryl groups) in asth-
matic patients.
Subjects and methods: 120 asthmatic patients and 120 healthy controls were genotyped for SIRT-
1 gene rs2273773 C > T SNP using polymerase chain reaction – confronting two pair primer
method (PCR-CTPP). Serum protein carbonyl and sulfhydryl groups were measured using colori-
metric methods.
Results: SIRT-1 gene rs2273773 C > T SNP genotyping revealed that the TT genotype was sig-
nificantly higher in the patients compared to the controls (P < 0.05), while there were no significant
differences regarding the genotypes TC and CC between the patients and the controls (P> 0.05). T
allele was significantly higher in the patients compared to the controls (P = 0.017). The distribution
of the genotypes didn’t differ among the atopic and the non-atopic asthmatic patients, also no dif-
ference was found in the genotype distribution according to the severity of asthma (P > 0.05).
Serum protein carbonyl group concentration was significantly higher in the patients compared to
the controls (P < 0. 001), while serum protein sulfhydryl group content decreased significantly in
the patients compared to the controls (P < 0.0001). No differences in markers of protein oxidation
according to SIRT-1 gene rs2273773 C > T genotype were found.
Conclusion: SIRT-1 gene rs2273773 C > T SNP was associated with asthma but not with
protein oxidation markers in Egyptian population.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Asthma is a chronic inflammatory disease of the airways with a
complex etiology [1]. The interaction of genes and environmen-
tal factors affects the development of asthma and determines
the expression or progression of the disease [2]. Epigenetic
mechanisms such as DNA methylation and histone modifica-
tion control the accessibility of the genome and manage gene
transcription in response to the environment in a heritable fash-
ion. Recent evidence suggests that these mechanisms play a role
in allergy and asthma [3]. SIRT-1 is a NAD+dependent
nuclear deacetylase of 747 residues, involved in various impor-
tant metabolic pathways. It down-regulates p53 activity, rising
lifespan, and cell survival and deacetylases peroxisome
proliferator-activated receptor-gamma and its coactivator 1
alpha, promoting lipid mobilization [4]. SIRT-1 can directly
modify chromatin, silence transcription and modulate the cellu-
lar proliferation. It possesses a probable antiaging effect
through increasing the genomic stability suppressing recombi-
nant DNA recombination [5,6]. SIRT-1 gene is located to chro-
mosome 10 (10q21.3) and has many single nucleotide
polymorphisms (SNPs), of which the SNP rs2273773 C > T,
a silent mutation in exon 5, was found to be associated with
many diseases including chronic obstructive pulmonary disease,
hypertension, type 2 diabetes and cardiovascular disease [7–9].
Oxidative stress was found to play an important role in asthma
pathogenesis [10]. Reactive oxygen species (ROS) attack pro-
teins causing their oxidation by forming carbonyl groups. The
amino acids; lysine, arginine, proline, and histidine are the most
liable to modification [11]. The bulk of protein sulfhydryl in
plasma is represented by Cys-34 of albumin. Protein sulfhydryl
acts as an antioxidant reacting with ROS, protecting cells
against the damage induced by them [12].
In this investigation, we aimed to study SIRT-1 gene
rs2273773 C > T SNP and serum markers of protein oxida-
tion (protein carbonyl group concentration and protein sulfhy-
dryl group content) in asthmatic patients. Also, we studied the
association between SIRT-1 gene rs2273773 C > T SNP and
the type and severity of asthma.
2. Materials and methods
2.1. Study population
The study was approved by the Ethics committee of Sohag
Faculty of Medicine and was in accordance with the Helsinki
Declaration of 1975. An informed written consent was
obtained from all individuals included in the study. 120 asth-
matic patients and 120 healthy controls were enrolled in the
study. The patients were recruited from the chest disease
department of Sohag University Hospital, the diagnosis of
asthma was according to the clinical history, physical examina-
tion, and pulmonary function tests, including reversibility test-
ing and measurement of bronchial reactivity. Patients were
classified into atopic and non-atopic and further as having
mild intermittent, mild moderate or severe persistent asthma.
Atopic asthma and non-atopic asthma were defined based on
the presence or absence of atopy (any skin prick test
P3 mm). In addition, IgE antibodies and eosinophil count
were evaluated for all the participants to differentiate between
atopic and non-atopic asthma [13]. The exclusion criteria werethe presence of hypertension, diabetes mellitus or any other
chronic disease, as SIRT-1 gene rs2273773 C > T SNP has
been established to be associated with blood pressure and
hyperglycemia in previous studies [7,9].
2.2. Blood samples and laboratory investigations
Fasting blood samples (about 5 ml) were collected from the
patients and the controls via the venipuncture of an antecubital
vein. Samples were divided into two parts; one taken in tubes
containing Na2-EDTA (final concentration 1 mg/ml) for geno-
mic DNA extraction and the other part was taken into plain
tubes and the serum of it was used for the routine laboratory
investigations (blood glucose and lipid profile) and for the esti-
mation of IgE antibodies, protein carbonyl and sulfhydryl
groups. Total cholesterol (TC), high density lipoprotein choles-
terol (HDL-C), triglycerides (TG) and fasting glucose were
determined using an enzymatic method on Cobas C 311 ana-
lyzer (Roche diagnostics, Germany). Low-density lipoprotein-
cholesterol (LDL-C) was calculated using the Friedewald for-
mula. IgE was measured using an ELIZA kit (ab108650),
according to the enclosed instructions. The assay range of the
kit was from 5 to 800 IU/ml.
2.3. Assay of serum protein carbonyl group concentration
Protein carbonyl group concentration was measured according
to the method of Reznick and Packer [14] with some modifica-
tions; as follows, two tubes of 200 lL serum were taken, one as
a test and the other as a control. After that, 1.0 ml of 10 mM
2,4 dinitrophenyl-hydrazine (DNPH) prepared in 1.25 M HCl
was added to the test sample and 1.0 ml of 2.5 M HCl alone
was added to the control sample. The contents were mixed
and incubated in the dark at room temperature for 1 h and
shaken intermittently every 15 min. Then 1.25 ml of 20% tri-
chloroacetic acid (TCA) (w/v) was added to both tubes and
the mixture left in ice for 10 min. The samples then underwent
centrifugation at 3500 rpm for 20 min to get the protein pellet
and the supernatant carefully discarded. This was followed by
a second wash with 10% TCA. Finally the precipitates were
washed three times with 1 ml of ethanol: ethyl acetate (1:1,
v/v) to remove unreacted DNPH and lipid remnants. The final
protein pellet was dissolved in 1 ml of 6 M guanidine
hydrochloride (GuHCL) and incubated at 37 C for 10 min.
The insoluble materials were removed by centrifugation. Car-
bonyl concentrations were determined from the difference in
absorbance at 370 nm between the test and the control sam-
ples, with e370 = 22,000 M1 cm1 (the molar extinction coef-
ficient of DNPH). Carbonyl levels were expressed as nmol/mg
protein.
2.4. Assay of serum protein sulfhydryl group content
It is determined according to thiol/disulfide reaction of thiol
and Ellman’s reagent (5,50-dithiobisnitrobenzoic acid, DTNB)
[15]. 50 lL of serum was mixed with 1 ml 0.1 M Tris, 10 mM
EDTA PH 8.2, constituting the blank reaction and assessed
at 412 nm. After that, we added 40 lL 10 mM DTNB in
methanol and the absorption was read at 412 nm after stable
color formation (1–3 min). The concentrations of protein
sulfhydryl groups were calculated using a molar extinction
Figure 1 Representative agarose gel electrophoresis showing
SIRT-1 gene rs2273773 C > T SNP, lane 1; 100 bp marker, lanes
2, 4 and 5 represent TT genotype, lane 3 represents CC genotype,
lanes 6 and 7 represent TC genotype.
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were expressed as nmol/mg protein.
2.5. DNA isolation
Genomic DNA was isolated from the buffy coat of the samples
taken in Na2-EDTA tubes (final concentration 1 mg/ml) after
centrifugation at 3000 rpm for 15 min at room temperature
using DNA isolation kit (illustra blood genomic Prep Mini
Spin Kit, supplied by GE Healthcare), according to the man-
ufacturer’s instructions. The DNA isolated using the kit has
a characteristic band size of approximately 20 kb on an agar-
ose gel. The yield of genomic DNA was measured by UV
absorbance and the purity of it was measured by A260/A280
(less than 1.7).
2.6. Determination of SIRT1 gene polymorphism
SIRT1 rs2273773 C > T SNP in exon 5 was analyzed using
PCR-CTPP (polymerase chain reaction–confronting two pair
primer) assay as described previously [8]. Two pairs of primers;
forward 1 (F1), reverse 1 (R1), forward 2 (F2) and reverse 2
(R2), synthesized by eurofins Genomics, were used for the
amplification. Table 1 showed the primers sequences, their
melting temperature, G-C content and the products obtained.
Briefly; 25 lL total PCR mixtures containing 100–200 ng
DNA, 10.0 pmol of each primer, 1.0 mM dNTP (deoxynu-
cleotide triphosphates), 25 mM MgCl2 and 2.5U Taq DNA
polymerase in the supplied reaction buffer (Taq Buffer with
(NH4)2SO4) were prepared. The PCR cycling conditions were
as follows; initial denaturation at 95 C for 10 min., 30 cycles
of 95 C for 1 min., 63 C 1 min., and 72 C for 1 min. and
additionally the final step at 72 C for 5 min. PCR products
were separated on a 2% agarose gel stained with ethidium
bromide and genotyped. Three genotypes were defined by 3
distinctive banding patterns 314, 228 bp for CC genotype;
314, 228, 135 bp for CT genotype; and 314, 135 bp for TT
genotype (Fig. 1).
2.7. Statistical analysis
Genotype distribution was tested for HWE (Hardy–Weinberg
equilibrium) by x2 analysis. The association between asthma
and genotype was calculated using the Chi-square test. Stu-
dent’s t test was used to compare the differences between con-
trols and patients regarding the demographic and laboratory
data. Anova test was used to compare the differences among
the patients’ groups. Results were expressed as mean ± SD
or number and percent. A two-tailed value of P < 0.05 was
considered statistically significant. All statistical calculations
were performed using the computer program SPSS (StatisticalTable 1 Primers used for the amplification.
Primers Sequence
Forward-1 (F-1) 5-GTGTGTCGCATCCATCTAGATAC- 3
Forward-2 (F-2) 5-CTCTCTGTCACAAATTCATAGCCT-3
Reverse-1 (R-1) 5-GTAGTTTTCCTTCCTTATCTGACAG-3
Reverse-2 (R-2) 5-CTGAAGTTTACTAACCATGACACTG-3Package for the Social Science; SPSS, Chicago, IL, version 16
for Microsoft Windows, USA).
3. Results
SIRT-1 gene rs2273773 C > T SNP was in Hardy–Weinberg
equilibrium for both the patients and the controls. The results
of the investigation revealed that there were no significant dif-
ferences between the patients and the controls regarding age,
sex, blood pressure, blood glucose, total cholesterol, triglyc-
eride and LDL-C. However, there were significant differences
in HDL-C, eosinophil count and IgE level (P < 0.05). Protein
carbonyl group concentration increased significantly
(P< 0.001), while protein sulfhydryl group content decreased
(P< 0.0001) in asthma patients compared to controls, Table 2.
SIRT-1 gene rs2273773 C > T SNP genotyping revealed that
the TT genotype was significantly higher in the patients com-
pared to the controls (P < 0.05) and there were no significant
differences regarding the genotypes TC and CC (P > 0.05),
however, TC genotype was higher in the controls but didn’t
reach the significant level (P = 0.07). T allele was significantly
higher in the patients compared to the controls (P = 0.017),
Table 3. The distribution of the genotypes didn’t differ among
the atopic and the non-atopic asthmatic patients, Table 4. No
difference was found in the genotype distribution according to
the severity of asthma (P > 0.05), Table 5. The markers of
protein oxidation didn’t differ according to the genotype in
both the patients and the controls (P > 0.05), Fig. 2.
4. Discussion
In this investigation, the association between SIRT-1 gene
rs2273773 C > T single nucleotide polymorphism, protein oxi-Tm GC-content (%) Products
60.6 C 47.8 314, 228 bp for CC
59.3 C 41.1 314, 228, 135 bp for CT
59.7 C 40
59.7 C 40 314, 135 bp for TT





Age (years) 45.5 ± 11 46.6 ± 10.8
Systolic Bp (mmHg) 120 ± 11 125 ± 10
Diastolic BP(mmHg) 70 ± 8.6 75 ± 7.6
Glucose (mg/dl) 90 ± 5.5 100 ± 4.7
Total cholesterol (mg/dl) 191.9 ± 12.2 195 ± 8.7
Triglyceride (mg/dl) 111 ± 28.4 95.4 ± 20.5
HDL-C (mg/dl) 39.4 ± 3.5 28.7 ± 3.6*
LDL-C (mg/dl) 103.7 ± 14.3 112.5 ± 11.5
Eosinophils/mm3 178.5 ± 65.4 400 ± 201***
Type of asthma
Atopic, n (%) – 79 (66)
Non-atopic, n (%) – 41 (34)
Severity of dis.
Mild, n (%) – 55 (46)
Moderate, n (%) – 35 (29)
Severe, n (%) – 30 (25)
IgE (IU/ml) 70 ± 20 135.6 ± 40**
Protein carbonyl (nmol/mg) 2.5 ± 0.63 3.75 ± 0.9**
Protein sulfhydryl (nmol/
mg)










TT, n (%) 22 (18.33) 42 (35) 8.5 0.0035*
TC, n (%) 70 (58.33) 56 (46.7) 3.27 0.07
CC, n (%) 28 (32.33) 22 (18.3) 0.9 0.34
T-allele, n
(%)
114 (47.5) 140 (58.3) 5.56 0.017*
C-allele, n
(%)
126 (52.5) 100 (41.7)
* P< 0.05.







TT, n (%) 27 (34.1) 15 (36.6) 0.07 0.8
TC, n (%) 36 (45.6) 20 (48.8) 0.11 0.7
CC, n (%) 16 (20.3) 6 (14.6) 0.57 0.45
T-allele, n (%) 90 (57) 50 (61) 0.36 0.55
C-allele, n (%) 68 (43) 32 (39)









TT, n (%) 20 (36.4) 12 (34.3) 10 (33.3)
TC, n (%) 30 (54.5) 14 (40) 12 (40) 8.5 0.39
CC, n (%) 5 (9.1) 9 (25.7) 8 (26.6)
T-allele, n
(%)
70 (63.6) 38 (54.3) 32 (53.3)
C-allele, n
(%)
40 (36.4) 32 (45.7) 28 (46.7)
X2 and P of chi-square for 3  5 table.
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was examined. Our results showed that there was an associa-
tion between TT genotype and T-allele and asthma. Protein
carbonyls increased while protein sulfhydryl decreased in
asthmatics compared to controls.SIRT-1 gene polymorphism was studied and found to be
associated with many diseases [7–9]. SIRT-1 gene rs2273773
C > T SNP, a silent mutation in exon 5, was found to be asso-
ciated with hypertension and hyperglycemia in Japanese [9]. In
another study, TT genotype and T-allele were found to be
increased in cardiovascular disease patients as compared to
controls and the risk of having cardiovascular disease
increased 1.9 times in carriers of T-allele [7]. However, a study
on the genetic variation of SIRT1 and its effects on human
longevity revealed that, the mortality rate didn’t differ among
the genotypes of SIRT-1 gene rs2273773 C > T SNP after
18 years follow up in cohort of white individuals of Dutch in
The Netherlands [16]. The association between SIRT-1 gene
rs2273773 C > T SNP and bronchial asthma may be due to
the effect on SIRT-1 protein expression, which in turn affects
the inflammation occurring in asthma [8].
Bronchial asthma represents a serious health problem as it
was found that 5% to 10% of the population suffer from
asthma. Many genes have been found to be implicated in the
pathogenesis of asthma. In identical twins if one is affected,
the probability of the other having the disease is approximately
25%. By the end of 2005, 25 genes had been associated with
asthma in more than six populations [17]. The hallmarks of
bronchial asthma are the increase in responsiveness and infil-
tration of airways by the inflammatory cells which is exacer-
bated by the cytokines produced by T-helper cells. SIRT1 is
a NAD+ dependent histone deacetylase [18]. It also, deacety-
lates several transcription factors, responsible for metabolism,
endocrine signaling, and inflammation, including peroxisome
proliferator-activated receptor-c (PPAR-c), PPAR-c coactiva-
tor 1-a [19], forkhead box transcription factor, p53 [20], and
nuclear factor kB (NF-kB) [21–22]. SIRT1 regulates
hypoxia-inducible factor 1-a (HIF1-a) activity and stabiliza-
tion [23–24]. Studies in cultured renal medullary interstitial
cells have shown that SIRT1 protects from oxidative injury
and hypoxia via deacetylation and activation of HIF1-a [25].
SIRT1 has been shown to regulate pro-inflammatory mediator
release in sustained inflammation and aging of the lungs. It
was reported that SIRT1 protein expression and enzyme activ-
ity were increased in a murine model of allergen-induced air-
way inflammation [24]. It was reported that mice lacking
SIRT1 catalytic activity exhibited an exaggerated response to
hypoxia within 1 week of exposure compared to the wild type
mice [26]. SRT1720, a pharmacological SIRT1 activator was
found to protect against Type II alveolar epithelial cells apop-
tosis in rats with emphysema induced by exposure to cigarette
Figure 2 No significant difference in protein group concentration (nmol/mg protein) in the controls (A) and patients (B) according to the
genotype (P > 0.05). Also, no difference in protein sulfhydryl content (nmol/mg protein) in controls (C) and patients (D) according to the
genotype (P > 0.05).
Sirtuin 1 gene rs2273773 C > T single nucleotide polymorphism 195smoke and in vivo intratracheal instillation of lipopolysaccha-
ride. SRT1720 improved lung function including airway resis-
tance and pulmonary dynamic compliance. Treatment mice
with SRT1720 up-regulated the levels of surfactant protein
(SP)A, SPC, SIRT1 and forkhead box O 3, increased SIRT1
activity, down-regulated the level of p53 and inhibited type
II alveolar epithelial cells apoptosis [26].
This investigation revealed increased protein oxidation in
asthmatic patients represented by an increase in protein car-
bonyls and a decrease in protein sulfhydryls. Oxidative stress
(oxidant-antioxidant imbalance) has been increasingly
recognized as a major factor contributing to the chronic
inflammation present in asthmatics and was reported by many
investigators [10,27–28].
This is the first study of SIRT-1 gene rs2273773 C > T SNP
in asthmatic Egyptian population. The limitation of the study
was the low number of participants, so further studies in which
larger population and the mechanisms by which SNP in SIRT1
gene affect asthma pathogenesis are required.5. Conclusion
The study revealed an association between SIRT-1 gene
rs2273773 C > T SNP and asthma in Egyptian population.
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